Joel Greenblatt’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$559K Buy
21,672
+11,533
+114% +$249K ﹤0.01% 1563
2026
Q2
$205K Buy
+10,139
New +$205K ﹤0.01% 1733
2026
Q1
– Sell
-27,802
Closed -$745K – 1760
2025
Q4
$745K Buy
27,802
+12,438
+81% +$320K ﹤0.01% 1337
2025
Q3
$409K Buy
15,364
+1,350
+10% +$34.9K ﹤0.01% 1426
2025
Q2
$322K Buy
14,014
+3,144
+29% +$78K ﹤0.01% 1441
2025
Q1
$315K Sell
10,870
-17,578
-62% -$561K ﹤0.01% 1351
2024
Q4
$1.06M Sell
28,448
-7,290
-20% -$333K 0.01% 898
2024
Q3
$1.73M Buy
35,738
+8,063
+29% +$354K 0.02% 766
2024
Q2
$1.11M Sell
27,675
-1,206
-4% -$50K 0.01% 859
2024
Q1
$1.27M Buy
28,881
+17,551
+155% +$906K 0.02% 785
2023
Q4
$701K Buy
11,330
+6,799
+150% +$357K 0.01% 893
2023
Q3
$208K Sell
4,531
-460
-9% -$25.1K ﹤0.01% 1232
2023
Q2
$287K Sell
4,991
-3,506
-41% -$155K 0.01% 1131
2023
Q1
$319K Sell
8,497
-11,765
-58% -$386K 0.01% 1110
2022
Q4
$568K Sell
20,262
-2,770
-12% -$80.4K 0.02% 857
2022
Q3
$647K Sell
23,032
-16,400
-42% -$535K 0.02% 786
2022
Q2
$1.37M Buy
39,432
+28,492
+260% +$1.02M 0.04% 473
2022
Q1
$393K Buy
+10,940
New +$310K 0.01% 868
2016
Q4
– Sell
-25,915
Closed -$492K – 937
2016
Q3
$492K Buy
25,915
+6,336
+32% +$115K 0.01% 712
2016
Q2
$316K Buy
+19,579
New +$276K ﹤0.01% 801

Other funds holding AMPH

Joel Greenblatt's AMPH Position: Q3 2026 in Review

Joel Greenblatt increased its Amphastar Pharmaceuticals (AMPH) stake by 114% in Q3 2026, buying an estimated $249K and bringing the position to 21,672 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.

Joel Greenblatt first reported a position in AMPH in Q2 2016 and has held it in 20 quarters since. The position peaked at $1.73M in Q3 2024. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Joel Greenblatt held 21,672 shares of Amphastar Pharmaceuticals worth $559K as of Q3 2026.
  • Joel Greenblatt bought 11,533 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $249K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1563 holding.
  • Joel Greenblatt first reported a position in Amphastar Pharmaceuticals in Q2 2016 and has held it in 20 quarters since.
  • Joel Greenblatt's Amphastar Pharmaceuticals position peaked at $1.73M in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.